secwatch.observer — SEC 8-K summary
======================================

Issuer:     Anebulo Pharmaceuticals, Inc. (ANEB)
CIK:        0001815974
Form:       8-K
Filed at:   2023-11-21T23:59:59+00:00
Accession:  0001493152-23-042292
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Anebulo stockholders approve increase in authorized shares and re-elect directors
--------------------------------------------------------------------------------

- Stockholders re-elected Jason M. Aryeh and Bimal Shah as Class III directors with ~23.1M votes for each.
- Ratified EisnerAmper LLP as independent auditor for fiscal 2024 (23,302,065 for, 2,075 against).
- Approved amendment to increase authorized common shares from 40M to 50M (23,263,127 for).
- The authorized share amendment was filed with Delaware Secretary of State on Nov 20, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815974/000149315223042292/0001493152-23-042292-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815974/000149315223042292/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-042292

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer